Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD

scientific article published on 17 April 2013

Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1212/WNL.0B013E318292A31D
P932PMC publication ID3908354
P698PubMed publication ID23596065

P50authorPaola PicciniQ64856193
Marios PolitisQ64856266
Clare LoaneQ122914799
P2093author name stringDavid J Brooks
Kit Wu
Peter Bain
P2860cites workSerotonergic mediated body mass index changes in Parkinson's disease.Q53222060
Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the ratQ71139950
Hemibody tremor related to strokeQ72628547
???Q64916150
Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brainQ34230368
Consensus nomenclature for in vivo imaging of reversibly binding radioligandsQ34630958
Distribution volume ratios without blood sampling from graphical analysis of PET dataQ36817029
Levodopa therapy in Parkinson's diseaseQ37967208
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET studyQ39343609
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structuresQ42794711
Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET studyQ42994792
Imaging essential tremorQ43076413
Overview of morphological changes in Parkinson's diseaseQ44129660
Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET studyQ44215550
Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET studyQ44324829
Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?Q45274909
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's diseaseQ46935041
Correction of head movement on PET studies: comparison of methods.Q48351156
Positron emission tomography quantification of [11C]-(+)-PHNO binding in the human brain.Q48398973
Delayed onset hand tremor caused by cerebral infarctionQ48537115
Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association.Q48615927
Delayed-onset posthemiplegic dystonia: CT demonstration of basal ganglia pathology.Q48899059
Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease.Q49095990
P433issue20
P407language of work or nameEnglishQ1860
P304page(s)1850-1855
P577publication date2013-04-17
P1433published inNeurologyQ1161692
P1476titleSerotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD
P478volume80

Reverse relations

cites work (P2860)
Q64866418Q64866418
Q47570664Analysis of 3D spatial trajectories in Parkinsonian, essential and physiological tremors
Q40790760Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate.
Q47952640Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease.
Q28397369Commentary: Evaluation of Models of Parkinson's Disease
Q48345426Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold?
Q39125374Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states
Q38734660Imaging synucleinopathies.
Q55287139Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET.
Q38156535Is action tremor in Parkinson's disease related to resting tremor?
Q40696539Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease
Q44523798Monoaminergic Modulation of Motor Cortex Function
Q35970595Motor Subtype as a Predictor of Future Working Memory Performance in Idiopathic Parkinson's Disease
Q48393606Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
Q30868628Neuroimaging in Parkinson disease: from research setting to clinical practice
Q35625767Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property space.
Q38126817Non-dopaminergic treatments for motor control in Parkinson's disease
Q30916063Recent imaging advances in neurology.
Q55428052Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [11C]DASB Positron Emission Tomography Study.
Q55050175Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.
Q48553538Serotonergic loss underlying apathy in Parkinson's disease.
Q92959120Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
Q33921178Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart
Q34880786Serotonin metabolites in the cerebrospinal fluid in sudden infant death syndrome
Q39055550Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies
Q34795714Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.
Q47849922The cerebral basis of Parkinsonian tremor: A network perspective
Q50238794The nature of postural tremor in Parkinson disease.
Q38124748The pathophysiology of essential tremor and Parkinson's tremor
Q33625060Treadmill exercise alleviates depressive symptoms in rotenone-induced Parkinson disease rats
Q38164869Tremor: pathophysiology
Q50017082[The new tremor classification of the International Parkinson and Movement Disorder Society : Update on frequent tremors].

Search more.